The diagnostics portfolio was expanded with ... Some of its current pipeline highlights include: Abbott Laboratories began its 125th year with approximately $22 billion in revenues and ...

Abbott Laboratories maintains a fortress-like balance ... Reported sales for the Diagnostics segment declined by 1.5% year-over-year (and grew by 3.3% organically) to $2.4 billion for the third ...

With a market cap of $202.2 billion, North Chicago, Illinois-based Abbott Laboratories (ABT) is a global healthcare company.

They’re at the center of a legal battle with the makers of specialized formulas for preterm infants — north suburban-based ...

and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States. Financial Insights: Abbott Laboratories Market Capitalization ...

As Abbott Laboratories prepares to build a plant and bring 450 jobs to Bowling Green, company officials asked for permission to have more fencing and less greenery than required by city zoning. On ...

In this article, we are going to take a look at where Abbott Laboratories (NYSE ... manufacture, and market diagnostic equipment and tests. Breakthroughs in medical technology, pharmaceuticals ...

Diversified Product Portfolio: Abbott Laboratories' diverse range of medical devices, diagnostic testing products, nutritional products, and branded generic pharmaceuticals is a significant strength.

Abbott Laboratories (NYSE:ABT) is a global healthcare leader producing a broad range of medical devices, diagnostics, nutritional products, and branded generic pharmaceuticals. Its top products ...

Abbott Laboratories showcases robust financial performance with a notable increase in net earnings. Strategic acquisitions ...